Tilray | TRLY - Ordinary Share Capital


Tilray reported $116.52M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Cronos Group USD 376.26M 5.33M Mar/2026
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Moderna USD 391M 2M Sep/2025
Organigram Holdings CAD 135.13M 671.75K Dec/2025
Organon & Co USD 260.32M 333K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025
Zealand Pharma A/S 70.61M 319.68K Dec/2025